N@N

Market Maker Surveillance Report. PNTV, SPY, PFE, AIG, NAK, ALPMY, Highest Net Sell Volume and Negative Price Friction For Fri

May 12, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Friday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Friday there were 5421 companies with "abnormal" market making, 2723 companies with positive Friction Factors and 3173 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Friday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. PLAYERS NETWORK Inc. (OTC:PNTV), SPDR S&P 500 (NYSE:SPY), Pfizer Inc. (NYSE:PFE), American International Group Inc. (NYSE:AIG), Northern Dynasty Minerals Ltd (NYSE:NAK), ASTELLAS PHARMA Inc. (OTC:ALPMY). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  PNTV    $-0.010   -0.17%    2,422,552    30.99%    5,395,579    69.01%    -2,973,027   -2,914,732
  SPY     $-0.200   -0.00%    10,149,329   22.34%    13,222,904   29.11%    -3,073,575   -153,679
  PFE     $-0.030   -0.00%    4,169,033    21.68%    7,802,161    40.57%    -3,633,128   -1,211,043
  AIG     $-0.790   -0.01%    2,737,661    13.73%    8,451,946    42.38%    -5,714,285   -72,333 
  NAK     $-0.340   -0.16%    12,566,164   35.40%    15,494,799   43.66%    -2,928,635   -86,136 
  ALPMY   $-0.195   -0.02%    73,992       2.03%     3,567,580    97.90%    -3,493,588   -179,158

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows PNTV down $-0.01020 with a Friction Factor of -2,914,732 and a Net Volume of -2,973,027. That means that it takes 2,914,732 more shares of selling than buying to drop PNTV by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

PLAYERS NETWORK Inc. (OTC:PNTV) - Players Network engages in the development of digital networks in the United States. The company distributes broadband video and other social media content through Internet enabled devices and cable television channels. Its programming brands include Players Network that focuses on gaming lifestyle, and produces programming about horse racing, sports betting, casino games, poker, and others; Vegas On Demand, which comprises Las Vegas lifestyle and covers celebrity, night clubs, poolside experiences, entertainment, and more; and Sexy Sin City TV covering the adult and sexy side of Las Vegas after dark. In addition, it operates Internet television platform; NexGenTV, a digital technology platform to distribute content for brands, businesses, and celebrities; Real Vegas TV; and Weed TV, a lifestyle channel destination powered by the company s NextGenTV enterprise platform. Further, the company focuses on pursuing the cultivation and processing of medical marijuana in North Las Vegas. It distributes gaming lifestyle media programming through various media platforms, including video on demand, broadband/Internet, satellite television, cable television, and packaged media, as well as through its Website. Players Network was founded in 1993 and is headquartered in Las Vegas, Nevada..

SPDR S&P 500 (NYSE:SPY) - S&P DEP RECEIPTS.

Pfizer Inc. (NYSE:PFE) - Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Viagra, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that will lose or have lost marketing patent protection; branded generic products; sterile injectable products; biosimilars; and infusion systems. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, and Pristiq brand names. This segment also engages in contract manufacturing business. The company has licensing agreements with Cellectis SA and AstraZeneca plc; and collaborative agreements with Eli Lilly & Company and Merck KGaA. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York..

American International Group Inc. (NYSE:AIG) - American International Group, Inc. provides insurance products for commercial, institutional, and individual customers primarily in the United States, Europe, and Japan. The company s Commercial Insurance segment offers general liability, environmental, commercial automobile liability, workers compensation, excess casualty, and crisis management insurance products, as well as various risk-sharing and other customized structured programs; commercial, industrial, and energy-related property insurance; aerospace, political risk, trade credit, surety, and marine insurance; and various insurance products for small and medium sized enterprises. It also provides professional liability insurance products for a range of businesses and risks, including directors and officers liability, fidelity, employment practices, fiduciary liability, cybersecurity risk, kidnap and ransom, and errors and omissions insurance. This segment sells its products through independent retail and wholesale brokers. Its Consumer Insurance segment offers fixed annuities, fixed index annuities, variable annuities, and retail mutual funds; group mutual funds, fixed annuities, and variable annuities, as well as individual annuity and investment products, and financial planning and advisory services; and term life and universal life insurance. Its products include personal auto and property insurance, voluntary and sponsor-paid personal accident, and supplemental health products; travel insurance products; and extended warranty insurance. This segment sells its products through independent marketing organizations, independent insurance agents, financial advisors, direct marketing, banks, wirehouses, and broker-dealers. The company also provides stable value wrap products, and structured settlement and terminal funding annuities; and corporate- and bank-owned life insurance and guaranteed investment contracts. American International Group, Inc. was founded in 1919 and is based in New York, New York..

Northern Dynasty Minerals Ltd (NYSE:NAK) - Northern Dynasty Minerals Ltd. engages in the exploration and development of mineral properties in the United States. Its principal property is the Pebble copper-gold-molybdenum mineral project located in southwest Alaska. The company was formerly known as Northern Dynasty Explorations Ltd. and changed its name to Northern Dynasty Minerals Ltd. in October 1997. Northern Dynasty Minerals Ltd. was founded in 1983 and is headquartered in Vancouver, Canada..

ASTELLAS PHARMA Inc. (OTC:ALPMY) - Astellas Pharma Inc., a pharmaceutical company, manufactures, markets, and imports/exports pharmaceutical products worldwide. The company offers Prograf, an immunosuppressant to prevent rejection in organ transplants; Vesicare, a treatment for overactive bladder; Protopic, a treatment for atopic dermatitis in the topical immunomodulator class; Harnal, a blocking agent to treat the functional symptoms of benign prostatic hyperplasia; and Funguard, a candin antifungal agent. It also provides Geninax, an oral new-type quinolone antibacterial agent; Celecox, a COX-2 inhibitor; Lipitor, a treatment for hypercholesterolemia; Micardis, a treatment for hypertension; Gaster, a treatment for peptic ulcers and gastritis; Myslee, a hypnotic; Cefzon, an oral cephalosporin; Seroquel, an antipsychotic agent; Dorner, a treatment for chronic arterial occlusion; Nasea, a 5-HT3 receptor antagonist; Regnite, a treatment for restless legs syndrome; and Kiklin, a treatment for hyperphatemia. In addition, the company offers Lexiscan and Adenoscan, which are pharmacologic stress agents; Tarceva, a treatment for non-small cell lung cancer; Vaprisol, a treatment for euvolemic hyponatremia; AmBisome, a systemic antifungal agent; Eligard, a treatment for advanced prostate cancer; Locoid, a topical corticosteroid; Zineryt, a treatment for acne; Locobase, a treatment for dry skin; and Dificlir, a novel treatment for CDI. It has collaboration agreements with The University of Texas MD Anderson Cancer Center; Potenza Therapeutics, Inc.; Kanyos Bio, Inc.; Chromocell Corporation; and Ocata Therapeutics, Inc. The company also has license agreement with Immunomic Therapeutics, Inc.; collaborative research agreements with the National Institute of Advanced Industrial Science and Technology and GenomeDx Biosciences; and collaborative development agreement with the Institute of Medical Science, the University of Tokyo. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net